The global Radiopharmaceutical market size was US$ 6678 million in 2024 and is forecast to a readjusted size of US$ 10850 million by 2031 with a CAGR of 7.3% during the forecast period 2025-2031.

Radiopharmaceutical Sales Market

Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.

The radiopharmaceutical market is driven primarily by the growing prevalence of cancer and cardiovascular diseases, which require precise diagnostic tools for early detection and treatment. The increasing adoption of nuclear medicine imaging techniques, such as PET and SPECT scans, has further fueled demand for radiopharmaceuticals. Additionally, technological advancements in radiopharmaceuticals, along with the development of new radioisotopes for more targeted therapies, are expanding the applications of these drugs, making them critical in personalized medicine.

Despite the promising growth, the radiopharmaceutical market faces significant challenges, including the high cost of production and the short half-life of many radioisotopes, which complicates distribution and storage. Regulatory hurdles are another barrier, as radiopharmaceuticals require stringent approval processes due to their radioactive nature. Moreover, limited availability of specialized infrastructure and the shortage of trained professionals in nuclear medicine also hinder widespread adoption, especially in developing regions.

There is widespread awareness of the use of radiation and radioisotopes in medicine, particularly for diagnosis (identification) and therapy (treatment) of various medical conditions. In developed countries (a quarter of the world population) about one person in 50 uses diagnostic nuclear medicine each year, and the frequency of therapy with radioisotopes is about one-tenth of this.

Nuclear medicine uses radiation to provide information about the functioning of a person's specific organs, or to treat disease. In most cases, the information is used by physicians to make a quick diagnosis of the patient's illness. The thyroid, bones, heart, liver, and many other organs can be easily imaged, and disorders in their function revealed. In some cases radiation can be used to treat diseased organs, or tumours.

Over 10,000 hospitals worldwide use radioisotopes in medicine, and about 90% of the procedures are for diagnosis. The most common radioisotope used in diagnosis is technetium-99 (Tc-99m) accounting for about 80% of all nuclear medicine procedures and 85% of diagnostic scans in nuclear medicine worldwide.Over 50 million nuclear medicine procedures are performed each year, and demand for radioisotopes is increasing.

The global Radiopharmaceutical market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.

Market Segmentation

Scope of Radiopharmaceutical Sales Market Report

Report Metric	Details
Report Name	Radiopharmaceutical Sales Market
Forecasted market size in 2031	US$ 10850 million
CAGR	7.3%
Forecasted years	2025 - 2031
By Type: (Dominant Segment vs High-Margin Innovation)	Diagnostic Radiopharmaceuticals Therapeutic Radiopharmaceuticals
By Application: (Core Demand Driver vs Emerging Opportunity)	Oncology Cardiology Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company:	Cardinal Health, GE Healthcare, Jubilant Pharma, Novartis, Curium Pharma, SIEMENS, Lantheus, Bracco Imaging, Bayer, Eli Lilly, Aurobindo Pharma, Mundipharma, China Isotope & Radiation, Dongcheng
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Radiopharmaceutical market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Therapeutic Radiopharmaceuticals in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Cardiology in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
This is not just another market study. By fusing global trend analysis with hyper-local operational intelligence, we deliver:
- Risk-Controlled Market Entry: Navigate regulatory complexities in focus markets (e.g., China’s policies).
- Product Portfolio Optimization: Align offerings with regional preferences (e.g., Diagnostic Radiopharmaceuticals dominance in Europe vs. Therapeutic Radiopharmaceuticals demand in MEA).
- Competitor Counterstrategies: Decode player tactics in fragmented vs. consolidated markets.

FAQ for this report

What is the Radiopharmaceutical Sales Market size in 2031?

Ans: The Radiopharmaceutical Sales Market size in 2031 will be US$ 10850 million.

Who are the main players in the Radiopharmaceutical Sales Market report?

Ans: The main players in the Radiopharmaceutical Sales Market are Cardinal Health, GE Healthcare, Jubilant Pharma, Novartis, Curium Pharma, SIEMENS, Lantheus, Bracco Imaging, Bayer, Eli Lilly, Aurobindo Pharma, Mundipharma, China Isotope & Radiation, Dongcheng

What are the Application segmentation covered in the Radiopharmaceutical Sales Market report?

Ans: The Applications covered in the Radiopharmaceutical Sales Market report are Oncology, Cardiology, Other

What are the Type segmentation covered in the Radiopharmaceutical Sales Market report?

Ans: The Types covered in the Radiopharmaceutical Sales Market report are Diagnostic Radiopharmaceuticals, Therapeutic Radiopharmaceuticals

1 Market Overview

1.1 Radiopharmaceutical Product Scope

1.2 Radiopharmaceutical by Type

1.2.1 Global Radiopharmaceutical Sales by Type (2020 & 2024 & 2031)

1.2.2 Diagnostic Radiopharmaceuticals

1.2.3 Therapeutic Radiopharmaceuticals

1.3 Radiopharmaceutical by Application

1.3.1 Global Radiopharmaceutical Sales Comparison by Application (2020 & 2024 & 2031)

1.3.2 Oncology

1.3.3 Cardiology

1.3.4 Other

1.4 Global Radiopharmaceutical Market Estimates and Forecasts (2020-2031)

1.4.1 Global Radiopharmaceutical Market Size in Value Growth Rate (2020-2031)

1.4.2 Global Radiopharmaceutical Market Size in Volume Growth Rate (2020-2031)

1.4.3 Global Radiopharmaceutical Price Trends (2020-2031)

1.5 Assumptions and Limitations

2 Market Size and Prospective by Region

2.1 Global Radiopharmaceutical Market Size by Region: 2020 VS 2024 VS 2031

2.2 Global Radiopharmaceutical Retrospective Market Scenario by Region (2020-2025)

2.2.1 Global Radiopharmaceutical Sales Market Share by Region (2020-2025)

2.2.2 Global Radiopharmaceutical Revenue Market Share by Region (2020-2025)

2.3 Global Radiopharmaceutical Market Estimates and Forecasts by Region (2026-2031)

2.3.1 Global Radiopharmaceutical Sales Estimates and Forecasts by Region (2026-2031)

2.3.2 Global Radiopharmaceutical Revenue Forecast by Region (2026-2031)

2.4 Major Region and Emerging Market Analysis

2.4.1 North America Radiopharmaceutical Market Size and Prospective (2020-2031)

2.4.2 Europe Radiopharmaceutical Market Size and Prospective (2020-2031)

2.4.3 China Radiopharmaceutical Market Size and Prospective (2020-2031)

2.4.4 Japan Radiopharmaceutical Market Size and Prospective (2020-2031)

2.4.5 India Radiopharmaceutical Market Size and Prospective (2020-2031)

3 Global Market Size by Type

3.1 Global Radiopharmaceutical Historic Market Review by Type (2020-2025)

3.1.1 Global Radiopharmaceutical Sales by Type (2020-2025)

3.1.2 Global Radiopharmaceutical Revenue by Type (2020-2025)

3.1.3 Global Radiopharmaceutical Price by Type (2020-2025)

3.2 Global Radiopharmaceutical Market Estimates and Forecasts by Type (2026-2031)

3.2.1 Global Radiopharmaceutical Sales Forecast by Type (2026-2031)

3.2.2 Global Radiopharmaceutical Revenue Forecast by Type (2026-2031)

3.2.3 Global Radiopharmaceutical Price Forecast by Type (2026-2031)

3.3 Different Types Radiopharmaceutical Representative Players

4 Global Market Size by Application

4.1 Global Radiopharmaceutical Historic Market Review by Application (2020-2025)

4.1.1 Global Radiopharmaceutical Sales by Application (2020-2025)

4.1.2 Global Radiopharmaceutical Revenue by Application (2020-2025)

4.1.3 Global Radiopharmaceutical Price by Application (2020-2025)

4.2 Global Radiopharmaceutical Market Estimates and Forecasts by Application (2026-2031)

4.2.1 Global Radiopharmaceutical Sales Forecast by Application (2026-2031)

4.2.2 Global Radiopharmaceutical Revenue Forecast by Application (2026-2031)

4.2.3 Global Radiopharmaceutical Price Forecast by Application (2026-2031)

4.3 New Sources of Growth in Radiopharmaceutical Application

5 Competition Landscape by Players

5.1 Global Radiopharmaceutical Sales by Players (2020-2025)

5.2 Global Top Radiopharmaceutical Players by Revenue (2020-2025)

5.3 Global Radiopharmaceutical Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiopharmaceutical as of 2024)

5.4 Global Radiopharmaceutical Average Price by Company (2020-2025)

5.5 Global Key Manufacturers of Radiopharmaceutical, Manufacturing Sites & Headquarters

5.6 Global Key Manufacturers of Radiopharmaceutical, Product Type & Application

5.7 Global Key Manufacturers of Radiopharmaceutical, Date of Enter into This Industry

5.8 Manufacturers Mergers & Acquisitions, Expansion Plans

6 Region Analysis

6.1 North America Market: Players, Segments, Downstream and Major Customers

6.1.1 North America Radiopharmaceutical Sales by Company

6.1.1.1 North America Radiopharmaceutical Sales by Company (2020-2025)

6.1.1.2 North America Radiopharmaceutical Revenue by Company (2020-2025)

6.1.2 North America Radiopharmaceutical Sales Breakdown by Type (2020-2025)

6.1.3 North America Radiopharmaceutical Sales Breakdown by Application (2020-2025)

6.1.4 North America Radiopharmaceutical Major Customer

6.1.5 North America Market Trend and Opportunities

6.2 Europe Market: Players, Segments, Downstream and Major Customers

6.2.1 Europe Radiopharmaceutical Sales by Company

6.2.1.1 Europe Radiopharmaceutical Sales by Company (2020-2025)

6.2.1.2 Europe Radiopharmaceutical Revenue by Company (2020-2025)

6.2.2 Europe Radiopharmaceutical Sales Breakdown by Type (2020-2025)

6.2.3 Europe Radiopharmaceutical Sales Breakdown by Application (2020-2025)

6.2.4 Europe Radiopharmaceutical Major Customer

6.2.5 Europe Market Trend and Opportunities

6.3 China Market: Players, Segments, Downstream and Major Customers

6.3.1 China Radiopharmaceutical Sales by Company

6.3.1.1 China Radiopharmaceutical Sales by Company (2020-2025)

6.3.1.2 China Radiopharmaceutical Revenue by Company (2020-2025)

6.3.2 China Radiopharmaceutical Sales Breakdown by Type (2020-2025)

6.3.3 China Radiopharmaceutical Sales Breakdown by Application (2020-2025)

6.3.4 China Radiopharmaceutical Major Customer

6.3.5 China Market Trend and Opportunities

6.4 Japan Market: Players, Segments, Downstream and Major Customers

6.4.1 Japan Radiopharmaceutical Sales by Company

6.4.1.1 Japan Radiopharmaceutical Sales by Company (2020-2025)

6.4.1.2 Japan Radiopharmaceutical Revenue by Company (2020-2025)

6.4.2 Japan Radiopharmaceutical Sales Breakdown by Type (2020-2025)

6.4.3 Japan Radiopharmaceutical Sales Breakdown by Application (2020-2025)

6.4.4 Japan Radiopharmaceutical Major Customer

6.4.5 Japan Market Trend and Opportunities

6.5 India Market: Players, Segments, Downstream and Major Customers

6.5.1 India Radiopharmaceutical Sales by Company

6.5.1.1 India Radiopharmaceutical Sales by Company (2020-2025)

6.5.1.2 India Radiopharmaceutical Revenue by Company (2020-2025)

6.5.2 India Radiopharmaceutical Sales Breakdown by Type (2020-2025)

6.5.3 India Radiopharmaceutical Sales Breakdown by Application (2020-2025)

6.5.4 India Radiopharmaceutical Major Customer

6.5.5 India Market Trend and Opportunities

7 Company Profiles and Key Figures

7.1 Cardinal Health

7.1.1 Cardinal Health Company Information

7.1.2 Cardinal Health Business Overview

7.1.3 Cardinal Health Radiopharmaceutical Sales, Revenue and Gross Margin (2020-2025)

7.1.4 Cardinal Health Radiopharmaceutical Products Offered

7.1.5 Cardinal Health Recent Development

7.2 GE Healthcare

7.2.1 GE Healthcare Company Information

7.2.2 GE Healthcare Business Overview

7.2.3 GE Healthcare Radiopharmaceutical Sales, Revenue and Gross Margin (2020-2025)

7.2.4 GE Healthcare Radiopharmaceutical Products Offered

7.2.5 GE Healthcare Recent Development

7.3 Jubilant Pharma

7.3.1 Jubilant Pharma Company Information

7.3.2 Jubilant Pharma Business Overview

7.3.3 Jubilant Pharma Radiopharmaceutical Sales, Revenue and Gross Margin (2020-2025)

7.3.4 Jubilant Pharma Radiopharmaceutical Products Offered

7.3.5 Jubilant Pharma Recent Development

7.4 Novartis

7.4.1 Novartis Company Information

7.4.2 Novartis Business Overview

7.4.3 Novartis Radiopharmaceutical Sales, Revenue and Gross Margin (2020-2025)

7.4.4 Novartis Radiopharmaceutical Products Offered

7.4.5 Novartis Recent Development

7.5 Curium Pharma

7.5.1 Curium Pharma Company Information

7.5.2 Curium Pharma Business Overview

7.5.3 Curium Pharma Radiopharmaceutical Sales, Revenue and Gross Margin (2020-2025)

7.5.4 Curium Pharma Radiopharmaceutical Products Offered

7.5.5 Curium Pharma Recent Development

7.6 SIEMENS

7.6.1 SIEMENS Company Information

7.6.2 SIEMENS Business Overview

7.6.3 SIEMENS Radiopharmaceutical Sales, Revenue and Gross Margin (2020-2025)

7.6.4 SIEMENS Radiopharmaceutical Products Offered

7.6.5 SIEMENS Recent Development

7.7 Lantheus

7.7.1 Lantheus Company Information

7.7.2 Lantheus Business Overview

7.7.3 Lantheus Radiopharmaceutical Sales, Revenue and Gross Margin (2020-2025)

7.7.4 Lantheus Radiopharmaceutical Products Offered

7.7.5 Lantheus Recent Development

7.8 Bracco Imaging

7.8.1 Bracco Imaging Company Information

7.8.2 Bracco Imaging Business Overview

7.8.3 Bracco Imaging Radiopharmaceutical Sales, Revenue and Gross Margin (2020-2025)

7.8.4 Bracco Imaging Radiopharmaceutical Products Offered

7.8.5 Bracco Imaging Recent Development

7.9 Bayer

7.9.1 Bayer Company Information

7.9.2 Bayer Business Overview

7.9.3 Bayer Radiopharmaceutical Sales, Revenue and Gross Margin (2020-2025)

7.9.4 Bayer Radiopharmaceutical Products Offered

7.9.5 Bayer Recent Development

7.10 Eli Lilly

7.10.1 Eli Lilly Company Information

7.10.2 Eli Lilly Business Overview

7.10.3 Eli Lilly Radiopharmaceutical Sales, Revenue and Gross Margin (2020-2025)

7.10.4 Eli Lilly Radiopharmaceutical Products Offered

7.10.5 Eli Lilly Recent Development

7.11 Aurobindo Pharma

7.11.1 Aurobindo Pharma Company Information

7.11.2 Aurobindo Pharma Business Overview

7.11.3 Aurobindo Pharma Radiopharmaceutical Sales, Revenue and Gross Margin (2020-2025)

7.11.4 Aurobindo Pharma Radiopharmaceutical Products Offered

7.11.5 Aurobindo Pharma Recent Development

7.12 Mundipharma

7.12.1 Mundipharma Company Information

7.12.2 Mundipharma Business Overview

7.12.3 Mundipharma Radiopharmaceutical Sales, Revenue and Gross Margin (2020-2025)

7.12.4 Mundipharma Radiopharmaceutical Products Offered

7.12.5 Mundipharma Recent Development

7.13 China Isotope & Radiation

7.13.1 China Isotope & Radiation Company Information

7.13.2 China Isotope & Radiation Business Overview

7.13.3 China Isotope & Radiation Radiopharmaceutical Sales, Revenue and Gross Margin (2020-2025)

7.13.4 China Isotope & Radiation Radiopharmaceutical Products Offered

7.13.5 China Isotope & Radiation Recent Development

7.14 Dongcheng

7.14.1 Dongcheng Company Information

7.14.2 Dongcheng Business Overview

7.14.3 Dongcheng Radiopharmaceutical Sales, Revenue and Gross Margin (2020-2025)

7.14.4 Dongcheng Radiopharmaceutical Products Offered

7.14.5 Dongcheng Recent Development

8 Radiopharmaceutical Manufacturing Cost Analysis

8.1 Radiopharmaceutical Key Raw Materials Analysis

8.1.1 Key Raw Materials

8.1.2 Key Suppliers of Raw Materials

8.2 Proportion of Manufacturing Cost Structure

8.3 Manufacturing Process Analysis of Radiopharmaceutical

8.4 Radiopharmaceutical Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

9.1 Marketing Channel

9.2 Radiopharmaceutical Distributors List

9.3 Radiopharmaceutical Customers

10 Radiopharmaceutical Market Dynamics

10.1 Radiopharmaceutical Industry Trends

10.2 Radiopharmaceutical Market Drivers

10.3 Radiopharmaceutical Market Challenges

10.4 Radiopharmaceutical Market Restraints

11 Research Findings and Conclusion

12 Appendix

12.1 Research Methodology

12.1.1 Methodology/Research Approach

12.1.1.1 Research Programs/Design

12.1.1.2 Market Size Estimation

12.1.1.3 Market Breakdown and Data Triangulation

12.1.2 Data Source

12.1.2.1 Secondary Sources

12.1.2.2 Primary Sources

12.2 Author Details

12.3 Disclaimer

FEATURED COMPANIES

China Isotope & Radiation

List of Tables

Table 1. Global Radiopharmaceutical Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)

Table 2. Global Radiopharmaceutical Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)

Table 3. Global Market Radiopharmaceutical Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Table 4. Global Radiopharmaceutical Sales (K Dose) by Region (2020-2025)

Table 5. Global Radiopharmaceutical Sales Market Share by Region (2020-2025)

Table 6. Global Radiopharmaceutical Revenue (US$ Million) Market Share by Region (2020-2025)

Table 7. Global Radiopharmaceutical Revenue Share by Region (2020-2025)

Table 8. Global Radiopharmaceutical Sales (K Dose) Forecast by Region (2026-2031)

Table 9. Global Radiopharmaceutical Sales Market Share Forecast by Region (2026-2031)

Table 10. Global Radiopharmaceutical Revenue (US$ Million) Forecast by Region (2026-2031)

Table 11. Global Radiopharmaceutical Revenue Share Forecast by Region (2026-2031)

Table 12. Global Radiopharmaceutical Sales by Type (K Dose) & (2020-2025)

Table 13. Global Radiopharmaceutical Sales Share by Type (2020-2025)

Table 14. Global Radiopharmaceutical Revenue by Type (US$ Million) & (2020-2025)

Table 15. Global Radiopharmaceutical Price by Type (USD/Dose) & (2020-2025)

Table 16. Global Radiopharmaceutical Sales by Type (K Dose) & (2026-2031)

Table 17. Global Radiopharmaceutical Revenue by Type (US$ Million) & (2026-2031)

Table 18. Global Radiopharmaceutical Price by Type (USD/Dose) & (2026-2031)

Table 19. Representative Players of Each Type

Table 20. Global Radiopharmaceutical Sales by Application (K Dose) & (2020-2025)

Table 21. Global Radiopharmaceutical Sales Share by Application (2020-2025)

Table 22. Global Radiopharmaceutical Revenue by Application (US$ Million) & (2020-2025)

Table 23. Global Radiopharmaceutical Price by Application (USD/Dose) & (2020-2025)

Table 24. Global Radiopharmaceutical Sales by Application (K Dose) & (2026-2031)

Table 25. Global Radiopharmaceutical Revenue Market Share by Application (US$ Million) & (2026-2031)

Table 26. Global Radiopharmaceutical Price by Application (USD/Dose) & (2026-2031)

Table 27. New Sources of Growth in Radiopharmaceutical Application

Table 28. Global Radiopharmaceutical Sales by Company (K Dose) & (2020-2025)

Table 29. Global Radiopharmaceutical Sales Share by Company (2020-2025)

Table 30. Global Radiopharmaceutical Revenue by Company (US$ Million) & (2020-2025)

Table 31. Global Radiopharmaceutical Revenue Share by Company (2020-2025)

Table 32. Global Radiopharmaceutical by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiopharmaceutical as of 2024)

Table 33. Global Market Radiopharmaceutical Average Price by Company (USD/Dose) & (2020-2025)

Table 34. Global Key Manufacturers of Radiopharmaceutical, Manufacturing Sites & Headquarters

Table 35. Global Key Manufacturers of Radiopharmaceutical, Product Type & Application

Table 36. Global Key Manufacturers of Radiopharmaceutical, Date of Enter into This Industry

Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 38. North America Radiopharmaceutical Sales by Company (2020-2025) & (K Dose)

Table 39. North America Radiopharmaceutical Sales Market Share by Company (2020-2025)

Table 40. North America Radiopharmaceutical Revenue by Company (2020-2025) & (US$ Million)

Table 41. North America Radiopharmaceutical Revenue Market Share by Company (2020-2025)

Table 42. North America Radiopharmaceutical Sales by Type (2020-2025) & (K Dose)

Table 43. North America Radiopharmaceutical Sales Market Share by Type (2020-2025)

Table 44. North America Radiopharmaceutical Sales by Application (2020-2025) & (K Dose)

Table 45. North America Radiopharmaceutical Sales Market Share by Application (2020-2025)

Table 46. Europe Radiopharmaceutical Sales by Company (2020-2025) & (K Dose)

Table 47. Europe Radiopharmaceutical Sales Market Share by Company (2020-2025)

Table 48. Europe Radiopharmaceutical Revenue by Company (2020-2025) & (US$ Million)

Table 49. Europe Radiopharmaceutical Revenue Market Share by Company (2020-2025)

Table 50. Europe Radiopharmaceutical Sales by Type (2020-2025) & (K Dose)

Table 51. Europe Radiopharmaceutical Sales Market Share by Type (2020-2025)

Table 52. Europe Radiopharmaceutical Sales by Application (2020-2025) & (K Dose)

Table 53. Europe Radiopharmaceutical Sales Market Share by Application (2020-2025)

Table 54. China Radiopharmaceutical Sales by Company (2020-2025) & (K Dose)

Table 55. China Radiopharmaceutical Sales Market Share by Company (2020-2025)

Table 56. China Radiopharmaceutical Revenue by Company (2020-2025) & (US$ Million)

Table 57. China Radiopharmaceutical Revenue Market Share by Company (2020-2025)

Table 58. China Radiopharmaceutical Sales by Type (2020-2025) & (K Dose)

Table 59. China Radiopharmaceutical Sales Market Share by Type (2020-2025)

Table 60. China Radiopharmaceutical Sales by Application (2020-2025) & (K Dose)

Table 61. China Radiopharmaceutical Sales Market Share by Application (2020-2025)

Table 62. Japan Radiopharmaceutical Sales by Company (2020-2025) & (K Dose)

Table 63. Japan Radiopharmaceutical Sales Market Share by Company (2020-2025)

Table 64. Japan Radiopharmaceutical Revenue by Company (2020-2025) & (US$ Million)

Table 65. Japan Radiopharmaceutical Revenue Market Share by Company (2020-2025)

Table 66. Japan Radiopharmaceutical Sales by Type (2020-2025) & (K Dose)

Table 67. Japan Radiopharmaceutical Sales Market Share by Type (2020-2025)

Table 68. Japan Radiopharmaceutical Sales by Application (2020-2025) & (K Dose)

Table 69. Japan Radiopharmaceutical Sales Market Share by Application (2020-2025)

Table 70. India Radiopharmaceutical Sales by Company (2020-2025) & (K Dose)

Table 71. India Radiopharmaceutical Sales Market Share by Company (2020-2025)

Table 72. India Radiopharmaceutical Revenue by Company (2020-2025) & (US$ Million)

Table 73. India Radiopharmaceutical Revenue Market Share by Company (2020-2025)

Table 74. India Radiopharmaceutical Sales by Type (2020-2025) & (K Dose)

Table 75. India Radiopharmaceutical Sales Market Share by Type (2020-2025)

Table 76. India Radiopharmaceutical Sales by Application (2020-2025) & (K Dose)

Table 77. India Radiopharmaceutical Sales Market Share by Application (2020-2025)

Table 78. Cardinal Health Company Information

Table 79. Cardinal Health Description and Business Overview

Table 80. Cardinal Health Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 81. Cardinal Health Radiopharmaceutical Product

Table 82. Cardinal Health Recent Development

Table 83. GE Healthcare Company Information

Table 84. GE Healthcare Description and Business Overview

Table 85. GE Healthcare Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 86. GE Healthcare Radiopharmaceutical Product

Table 87. GE Healthcare Recent Development

Table 88. Jubilant Pharma Company Information

Table 89. Jubilant Pharma Description and Business Overview

Table 90. Jubilant Pharma Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 91. Jubilant Pharma Radiopharmaceutical Product

Table 92. Jubilant Pharma Recent Development

Table 93. Novartis Company Information

Table 94. Novartis Description and Business Overview

Table 95. Novartis Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 96. Novartis Radiopharmaceutical Product

Table 97. Novartis Recent Development

Table 98. Curium Pharma Company Information

Table 99. Curium Pharma Description and Business Overview

Table 100. Curium Pharma Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 101. Curium Pharma Radiopharmaceutical Product

Table 102. Curium Pharma Recent Development

Table 103. SIEMENS Company Information

Table 104. SIEMENS Description and Business Overview

Table 105. SIEMENS Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 106. SIEMENS Radiopharmaceutical Product

Table 107. SIEMENS Recent Development

Table 108. Lantheus Company Information

Table 109. Lantheus Description and Business Overview

Table 110. Lantheus Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 111. Lantheus Radiopharmaceutical Product

Table 112. Lantheus Recent Development

Table 113. Bracco Imaging Company Information

Table 114. Bracco Imaging Description and Business Overview

Table 115. Bracco Imaging Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 116. Bracco Imaging Radiopharmaceutical Product

Table 117. Bracco Imaging Recent Development

Table 118. Bayer Company Information

Table 119. Bayer Description and Business Overview

Table 120. Bayer Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 121. Bayer Radiopharmaceutical Product

Table 122. Bayer Recent Development

Table 123. Eli Lilly Company Information

Table 124. Eli Lilly Description and Business Overview

Table 125. Eli Lilly Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 126. Eli Lilly Radiopharmaceutical Product

Table 127. Eli Lilly Recent Development

Table 128. Aurobindo Pharma Company Information

Table 129. Aurobindo Pharma Description and Business Overview

Table 130. Aurobindo Pharma Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 131. Aurobindo Pharma Radiopharmaceutical Product

Table 132. Aurobindo Pharma Recent Development

Table 133. Mundipharma Company Information

Table 134. Mundipharma Description and Business Overview

Table 135. Mundipharma Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 136. Mundipharma Radiopharmaceutical Product

Table 137. Mundipharma Recent Development

Table 138. China Isotope & Radiation Company Information

Table 139. China Isotope & Radiation Description and Business Overview

Table 140. China Isotope & Radiation Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 141. China Isotope & Radiation Radiopharmaceutical Product

Table 142. China Isotope & Radiation Recent Development

Table 143. Dongcheng Company Information

Table 144. Dongcheng Description and Business Overview

Table 145. Dongcheng Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 146. Dongcheng Radiopharmaceutical Product

Table 147. Dongcheng Recent Development

Table 148. Production Base and Market Concentration Rate of Raw Material

Table 149. Key Suppliers of Raw Materials

Table 150. Radiopharmaceutical Distributors List

Table 151. Radiopharmaceutical Customers List

Table 152. Radiopharmaceutical Market Trends

Table 153. Radiopharmaceutical Market Drivers

Table 154. Radiopharmaceutical Market Challenges

Table 155. Radiopharmaceutical Market Restraints

Table 156. Research Programs/Design for This Report

Table 157. Key Data Information from Secondary Sources

Table 158. Key Data Information from Primary Sources

List of Figures

Figure 1. Radiopharmaceutical Product Picture

Figure 2. Global Radiopharmaceutical Sales (US$ Million) by Type (2020 & 2024 & 2031)

Figure 3. Global Radiopharmaceutical Sales Market Share by Type in 2024 & 2031

Figure 4. Diagnostic Radiopharmaceuticals Product Picture

Figure 5. Therapeutic Radiopharmaceuticals Product Picture

Figure 6. Global Radiopharmaceutical Sales (US$ Million) by Application (2020 & 2024 & 2031)

Figure 7. Global Radiopharmaceutical Sales Market Share by Application in 2024 & 2031

Figure 8. Oncology Examples

Figure 9. Cardiology Examples

Figure 10. Other Examples

Figure 11. Global Radiopharmaceutical Sales, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Radiopharmaceutical Sales Growth Rate (2020-2031) & (US$ Million)

Figure 13. Global Radiopharmaceutical Sales (K Dose) Growth Rate (2020-2031)

Figure 14. Global Radiopharmaceutical Price Trends Growth Rate (2020-2031) & (USD/Dose)

Figure 15. Radiopharmaceutical Report Years Considered

Figure 16. Global Market Radiopharmaceutical Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Figure 17. Global Radiopharmaceutical Revenue Market Share by Region: 2020 VS 2024

Figure 18. North America Radiopharmaceutical Revenue (US$ Million) Growth Rate (2020-2031)

Figure 19. North America Radiopharmaceutical Sales (K Dose) Growth Rate (2020-2031)

Figure 20. Europe Radiopharmaceutical Revenue (US$ Million) Growth Rate (2020-2031)

Figure 21. Europe Radiopharmaceutical Sales (K Dose) Growth Rate (2020-2031)

Figure 22. China Radiopharmaceutical Revenue (US$ Million) Growth Rate (2020-2031)

Figure 23. China Radiopharmaceutical Sales (K Dose) Growth Rate (2020-2031)

Figure 24. Japan Radiopharmaceutical Revenue (US$ Million) Growth Rate (2020-2031)

Figure 25. Japan Radiopharmaceutical Sales (K Dose) Growth Rate (2020-2031)

Figure 26. India Radiopharmaceutical Revenue (US$ Million) Growth Rate (2020-2031)

Figure 27. India Radiopharmaceutical Sales (K Dose) Growth Rate (2020-2031)

Figure 28. Global Radiopharmaceutical Revenue Share by Type (2020-2025)

Figure 29. Global Radiopharmaceutical Sales Share by Type (2026-2031)

Figure 30. Global Radiopharmaceutical Revenue Share by Type (2026-2031)

Figure 31. Global Radiopharmaceutical Revenue Share by Application (2020-2025)

Figure 32. Global Radiopharmaceutical Revenue Growth Rate by Application in 2020 & 2024

Figure 33. Global Radiopharmaceutical Sales Share by Application (2026-2031)

Figure 34. Global Radiopharmaceutical Revenue Share by Application (2026-2031)

Figure 35. Global Radiopharmaceutical Sales Share by Company (2024)

Figure 36. Global Radiopharmaceutical Revenue Share by Company (2024)

Figure 37. Global 5 Largest Radiopharmaceutical Players Market Share by Revenue in Radiopharmaceutical: 2020 & 2024

Figure 38. Radiopharmaceutical Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 39. Manufacturing Cost Structure of Radiopharmaceutical

Figure 40. Manufacturing Process Analysis of Radiopharmaceutical

Figure 41. Radiopharmaceutical Industrial Chain

Figure 42. Channels of Distribution (Direct Vs Distribution)

Figure 43. Distributors Profiles

Figure 44. Bottom-up and Top-down Approaches for This Report

Figure 45. Data Triangulation

Figure 46. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4250

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$6000

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$8000

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global SPECT and PET Radiopharmaceuticals Market Research Report 2024

Global Nuclear Medicine Market Research Report 2025

Global Radiopharmaceuticals in Nuclear Medicine Market Research Report 2025

Global Radiopharmaceutical Therapy Market Research Report 2025

Global Diagnostic Radiopharmaceuticals Market Research Report 2024

Global SPECT Radiopharmaceuticals Market Research Report 2025

Global Diagnostic Nuclear Medicines Market Insights Forecast to 2030

Global Radiopharmaceuticals for Diagnosis Market Research Report 2024

Global Diagnostic Radioisotopes Market Insights Forecast to 2030

Global Targeted Radiopharmaceuticals Market Research Report 2024

Global Radiopharmaceutical Injector Market Research Report 2025

Global PET Radioisotope Radiopharmaceuticals in PET Imaging Market Research Report 2024

Global Therapeutic Radiopharmaceuticals Market Insights Forecast to 2030

Radiopharmaceutical Theranostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Radioactive Therapeutic Drugs Market Research Report 2024

Global Therapeutic Radioisotopes Market Insights Forecast to 2030

Global Nuclear Radiopharmaceutical Market Insights Forecast to 2030

Global Radioisotopes in Medicine Market Research Report 2025

Global Medical Radioisotopes Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

[email protected]

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

	
		OSZAR »